Creska™ offers a homologous “Off-The-Shelf” Adipose Derived ECM that is intended to be used where skin and fat naturally exist and to perform the same basic function or functions of adipose tissue in the recipient as in the donor, such as cushioning and support for other tissues, including the skin and internal organs, storing energy in the form of lipids, and insulating the body, among other functions. ECM-C or ECM-D are not filtered for nor intended for systemic use.
These products meet all the criteria established by the U.S. FDA for HCT/Ps that are regulated solely under Section 361 of the PHS Act, and subject to 21CFR 1271.
© 2025 Disclaimer: Creska™ ECMs are not intended for transplantation and is not HLA type matched between a donor and a recipient for any type of systemic transplantation such as for intravenous use. HLA (Human Leukocyte Antigen) Tissue Typing is a procedure in which the tissues of a prospective donor and recipient are tested for compatibility prior to transplantation. Mismatched donor and recipient tissues can lead to rejection of the tissues. Creska™ is strictly for topical, cosmetic and subcutaneous use. This product is not intended for use in the treatment of any disease or condition.
What is Creska™?
Creska™ ECMs are derived from liposuction technology from thoroughly screened donors and its intended to be used only where skin and fat naturally exist. Creska contains a high concentration of factors known to be present in extracellular matrixes.
All products are produced in the United States by an FDA registered lab that is also conducting multiple FDA approved clinical trials in the regenerative medicine industry.
How does Creska™ work?
Creska™ ECMs are derived from dermal adipose tissue that is actually classified as skin as a homologous Adipose Derived ECM that behaves in the skin as it was naturally intended to perform the same basic function or functions of adipose tissue in the recipient as in the donor, such as cushioning and support for other tissues, including the skin and internal organs, storing energy in the form of lipids, and insulating the body, among other functions. ECM-C is not filtered for nor intended for systemic use
These ECMs can be used as a stand-alone product or possibly offered as a complement to FDA Cleared devices, or autologous treatments for cushioning and support for tissue, energy storage in the form of lipids and structure of the dermis for cosmetic applications.
